More on aprepitant for erlotinib-induced pruritus

N Engl J Med. 2011 Feb 3;364(5):487. doi: 10.1056/NEJMc1013027.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma / drug therapy
  • Aprepitant
  • Drug Interactions
  • Drug Therapy, Combination
  • Erlotinib Hydrochloride
  • Humans
  • Lung Neoplasms / drug therapy
  • Middle Aged
  • Morpholines / therapeutic use*
  • Neurokinin-1 Receptor Antagonists*
  • Off-Label Use
  • Protein Kinase Inhibitors / adverse effects*
  • Pruritus / chemically induced
  • Pruritus / drug therapy*
  • Quinazolines / therapeutic use*

Substances

  • Morpholines
  • Neurokinin-1 Receptor Antagonists
  • Protein Kinase Inhibitors
  • Quinazolines
  • Aprepitant
  • Erlotinib Hydrochloride